Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial

IMPORTANCE AND OBJECTIVES:. This study assessed the potential advantages of treating hepatorenal syndrome-acute kidney injury (HRS-AKI) with terlipressin versus placebo in the ICU setting. DESIGN:. Patients were randomly assigned in a 2:1 ratio to receive terlipressin or placebo for up to 14 days. S...

Full description

Bibliographic Details
Main Authors:	Constantine J. Karvellas, MD, Ram Subramanian, MD, Jody C. Olson, MD, Khurram Jamil, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-04-01
Series:	Critical Care Explorations
Online Access:	http://journals.lww.com/10.1097/CCE.0000000000000890

Similar Items

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
by: Jody C Olson, et al.
Published: (2024-01-01)

Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome
by: Xiaofeng Wang, et al.
Published: (2022-04-01)

Terlipressin and albumin for the hepatorenal syndrome.
by: Antoniades, C, et al.
Published: (2003)

Noradrenaline or terlipressin for hepatorenal syndrome?
by: Pilar Celis, et al.
Published: (2015-08-01)

Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome
by: Aneesh Basheer, et al.
Published: (2018-03-01)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
by: Michael P. Curry, et al.
Published: (2023-01-01)

A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design
by: Boyer TD, et al.
Published: (2012-07-01)

Low doses of terlipressin and albumin in the type I hepatorenal syndrome
by: Davide Pulvirenti, et al.
Published: (2013-05-01)

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
by: Muhammad A. Mujtaba, et al.
Published: (2023-09-01)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
by: Ahlam Ayyad, et al.
Published: (2023-09-01)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
by: Mohamed M G Mohamed, et al.
Published: (2021-08-01)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
by: Hae Rim Kim, et al.
Published: (2013-12-01)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
by: Anand V. Kulkarni, et al.
Published: (2022-04-01)

TERLIPRESSIN VERSUS NORADRENALINE FOR HEPATORENAL SYNDROME. Economic evaluation under the perspective of the Brazilian Public Health System
by: Ângelo Zambam de MATTOS, et al.

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY
by: Muhammad Siddique, et al.
Published: (2019-08-01)

Acute Kidney Injury in Poisoned Patients Admitted to ICU
by: Roghayeh Rashidi, et al.
Published: (2020-11-01)

Acute Kidney Injury and Hepatorenal Syndrome
by: Moon Young Kim, et al.
Published: (2018-08-01)

The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records
by: Khurram Jamil, MD, et al.
Published: (2022-01-01)

Hepatorenal syndrome
by: Andrés Cárdenas, M.D., et al.
Published: (2003-01-01)

Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis
by: Nazli Begum Ozturk, et al.
Published: (2023-12-01)

CONFIRMing Hepatorenal Syndrome Management: #NephJC Editorial
by: Jamie Willows, et al.
Published: (2022-01-01)

Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome
by: Ahmed Abdel-Razik, et al.
Published: (2020-01-01)

Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury: an IDEAL-ICU substudy
by: Saber Davide Barbar, et al.
Published: (2023-08-01)

Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats
by: Leticia Urbano Cardoso Castro, et al.
Published: (2022-11-01)

The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.
by: Ken Ishikawa, et al.
Published: (2012-01-01)

Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury
by: Roula Sasso, et al.
Published: (2021-11-01)

Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain
by: Madhumita Premkumar, et al.
Published: (2023-01-01)

Terlipressin Induced Severe Hyponatremia
by: Martin Šíma, et al.
Published: (2016-01-01)

Terlipressin‐induced foot ischemia
by: Fateen Ata, et al.
Published: (2021-01-01)

Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes
by: Muriel Ghosn, et al.
Published: (2021-03-01)

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome
by: V Kanubhai Sutariya, et al.
Published: (2015-07-01)

Early Bacterial Coinfections in Patients Admitted to the ICU With COVID-19 or Influenza: A Retrospective Cohort Study
by: Felix Bergmann, MD, et al.
Published: (2023-04-01)

Verified Hepatorenal Syndrome Reversal As A Robust Multi-Component Primary End Point: The CONFIRM Study Trial Design
by: Jamil K, et al.
Published: (2019-11-01)

Association Between Acute Kidney Injury During Invasive Mechanical Ventilation and ICU Outcomes and Respiratory System Mechanics
by: Sneha V. Vemuri, MBChB, et al.
Published: (2022-07-01)

Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin are early predictors for acute kidney injury among patients admitted to the surgical ICU
by: Mohammed F Abosamak, et al.
Published: (2021-01-01)

Ramipril poisoning rescued by naloxone and terlipressin
by: Samanta Samanta, et al.
Published: (2014-01-01)

Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies
by: Ashwani K. Singal, et al.
Published: (2023-01-01)

Prediction models combining zonulin, LPS, and LBP predict acute kidney injury and hepatorenal syndrome–acute kidney injury in cirrhotic patients
by: Yi-Hsuan Lin, et al.
Published: (2023-08-01)

Hepatorenal Syndrome
by: Pınar Zeyneloğlu
Published: (2012-04-01)

HEPATORENAL SYNDROME
by: Matjaž Hafner
Published: (2001-12-01)